
Wednesday, April 07, 2021 12:18:16 PM
Patient count for March increased by 388%
Announced that patient counts increased by 460% in Q1 2021 (26,317) versus Q1 2020 (5,717).
Patient counts for the month of March increased by 388% versus the same period in 2020 with total patient counts of 8,379 in March 2021 compared to 2,160 in March 2020.
VANCOUVER BC / April 7, 2021 / EMPOWER CLINICS INC. (CSE:CBDT)(FRA:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms and a high complexity medical diagnostics laboratory processing thousands of COVID-19 specimens, is pleased to announce that patient counts increased by 460% in Q1 2021 (26,317) versus Q1 2020 (5,717). Patient counts for the month of March increased by 388% versus the same period in 2020 with total patient counts of 8,379 in March 2021 compared to 2,160 in March 2020.
“The delivery of world-class patient care is the number one priority for our team in all the markets we serve.” said Steven McAuley, Chairman & CEO of Empower. “I am so proud of our members’ daily effort and dedication to patients even in such uncertain times. For our team to achieve such significant year-over-year growth numbers is a testament to our ability to execute on our business plan to acquire patients and drive long-term shareholder value. I’m especially proud of the strong growth in the last month of Q1 which sets us up for continued growth in Q2 2021”
The Company has also issued a total of 800,000 stock options priced at $0.57 CAD to investor relation service providers and to a Director of the Company.
This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management https://agoracom.com/ir/EmpowerClinics
Source: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/758635-empower-clinics-reports-q1-2021-patient-results-with-year-over-year-growth-of-460/messages/2311070#message
Tags: covid19, Covid19 testing, CSE, Diagnos Inc, investments, small cap, small cap stocks, stocks
This entry was posted on Wednesday, April 7th, 2021 at 7:57 am and is filed under Empower Clinics Inc.. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.
Comments are closed.

Liked By
Spread the love. Be the first to like this post!
Recent EPWCF News
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/06/2022 06:20:21 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/03/2022 10:07:29 AM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 10/27/2022 08:48:52 PM
- Royal Caribbean Lays Keel for New Ship • TipRanks • 04/05/2022 06:26:06 PM
FEATURED Lifecycle Assessment by Benchmark Shows TMC's NORI-D Nodule Project Could Outperform Land-Based Routes of Producing Nickel, Copper and Cobalt in Almost Every Impact Category Analyzed • Mar 22, 2023 1:44 PM
Nextech3D.ai Announces Its AI-Powered SaaS Platform Toggle3D Experiences A +963% Jump in Users in 60-Days Crossing Over 1000 Users • NTAR • Mar 23, 2023 7:07 AM
Fineqia Announces Partnership with Paris Blockchain Week to Accelerate Digital Asset Innovation • FNQQF • Mar 22, 2023 10:03 AM
E-Cite and ClearMarket Launch Nationwide EV Distribution Network Becoming the First All EV Dealership Opening in the Cerritos Auto Square, the World's Largest Automall • VAPR • Mar 22, 2023 9:41 AM
Electromedical Announces $1.36M Net Proceeds from Building Sale to Fund WellnessPro Infinity ™ Launch and Convertible Note Retirement. • EMED • Mar 22, 2023 7:04 AM
HealthLynked Corp. Awarded Patent 11,600,395 for "Secure Patient Access via Healthcare Service Provider Specific Wireless Access Point" • HLYK • Mar 21, 2023 8:00 AM